Beijing Strong Biotechnologies, Inc. (300406.SZ)
CNY 15.07
(-1.76%)
CNY 15.07
(-1.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.17 Billion CNY | 12.2% |
| 2022 | 4.61 Billion CNY | 6.79% |
| 2021 | 4.31 Billion CNY | 8.98% |
| 2020 | 3.96 Billion CNY | 84.01% |
| 2019 | 2.15 Billion CNY | 15.51% |
| 2018 | 1.86 Billion CNY | 4.84% |
| 2017 | 1.77 Billion CNY | 20.91% |
| 2016 | 1.47 Billion CNY | 16.59% |
| 2015 | 1.26 Billion CNY | 20.8% |
| 2014 | 1.04 Billion CNY | 100.52% |
| 2013 | 520.88 Million CNY | 20.44% |
| 2012 | 432.48 Million CNY | 36.56% |
| 2011 | 316.69 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 5.27 Billion CNY | 1.98% |
| 2024 Q3 | 5.45 Billion CNY | 2.99% |
| 2024 Q2 | 5.29 Billion CNY | 0.39% |
| 2023 Q3 | 4.96 Billion CNY | 3.54% |
| 2023 Q4 | 5.17 Billion CNY | 4.21% |
| 2023 Q1 | 4.68 Billion CNY | 1.61% |
| 2023 Q2 | 4.79 Billion CNY | 2.34% |
| 2023 FY | 5.17 Billion CNY | 12.2% |
| 2022 Q4 | 4.61 Billion CNY | 0.85% |
| 2022 FY | 4.61 Billion CNY | 6.79% |
| 2022 Q2 | 4.34 Billion CNY | 0.96% |
| 2022 Q1 | 4.3 Billion CNY | -0.41% |
| 2022 Q3 | 4.57 Billion CNY | 5.3% |
| 2021 Q4 | 4.31 Billion CNY | -9.8% |
| 2021 Q1 | 4.04 Billion CNY | 2.05% |
| 2021 Q2 | 4.18 Billion CNY | 3.53% |
| 2021 FY | 4.31 Billion CNY | 8.98% |
| 2021 Q3 | 4.78 Billion CNY | 14.37% |
| 2020 Q4 | 3.96 Billion CNY | 1.94% |
| 2020 Q3 | 3.88 Billion CNY | 76.06% |
| 2020 Q2 | 2.2 Billion CNY | -0.9% |
| 2020 Q1 | 2.22 Billion CNY | 3.47% |
| 2020 FY | 3.96 Billion CNY | 84.01% |
| 2019 Q2 | 1.85 Billion CNY | 0.44% |
| 2019 Q4 | 2.15 Billion CNY | 10.29% |
| 2019 Q1 | 1.84 Billion CNY | -1.01% |
| 2019 FY | 2.15 Billion CNY | 15.51% |
| 2019 Q3 | 1.95 Billion CNY | 5.34% |
| 2018 Q3 | 1.77 Billion CNY | 6.0% |
| 2018 FY | 1.86 Billion CNY | 4.84% |
| 2018 Q4 | 1.86 Billion CNY | 4.9% |
| 2018 Q2 | 1.67 Billion CNY | -3.13% |
| 2018 Q1 | 1.73 Billion CNY | -2.67% |
| 2017 Q3 | 1.54 Billion CNY | 5.09% |
| 2017 Q4 | 1.77 Billion CNY | 15.33% |
| 2017 FY | 1.77 Billion CNY | 20.91% |
| 2017 Q1 | 1.53 Billion CNY | 4.16% |
| 2017 Q2 | 1.46 Billion CNY | -4.23% |
| 2016 Q2 | 1.31 Billion CNY | -0.63% |
| 2016 Q4 | 1.47 Billion CNY | 6.7% |
| 2016 FY | 1.47 Billion CNY | 16.59% |
| 2016 Q1 | 1.31 Billion CNY | 4.52% |
| 2016 Q3 | 1.37 Billion CNY | 5.21% |
| 2015 Q2 | 1.11 Billion CNY | 1.63% |
| 2015 Q4 | 1.26 Billion CNY | 6.34% |
| 2015 Q3 | 1.18 Billion CNY | 6.8% |
| 2015 Q1 | 1.09 Billion CNY | 4.66% |
| 2015 FY | 1.26 Billion CNY | 20.8% |
| 2014 Q2 | 621.91 Million CNY | 0.0% |
| 2014 Q4 | 1.04 Billion CNY | 50.47% |
| 2014 Q3 | 694.14 Million CNY | 11.61% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 FY | 1.04 Billion CNY | 100.52% |
| 2013 Q4 | 520.88 Million CNY | 0.0% |
| 2013 FY | 520.88 Million CNY | 20.44% |
| 2012 FY | 432.48 Million CNY | 36.56% |
| 2011 FY | 316.69 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 17.93 Billion CNY | 71.149% |
| Hangzhou Tigermed Consulting Co., Ltd. | 29.69 Billion CNY | 82.572% |
| Dirui Industrial Co.,Ltd. | 3.32 Billion CNY | -55.86% |
| Medicalsystem Biotechnology Co., Ltd. | 3.48 Billion CNY | -48.337% |
| Maccura Biotechnology Co.Ltd | 8.11 Billion CNY | 36.253% |
| Guangzhou Wondfo Biotech Co.,Ltd | 5.77 Billion CNY | 10.326% |
| Guangdong Hybribio Biotech Co.,Ltd. | 5.72 Billion CNY | 9.606% |
| BGI Genomics Co., Ltd. | 13.61 Billion CNY | 61.979% |
| Amoy Diagnostics Co., Ltd. | 1.93 Billion CNY | -167.497% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 2.98 Billion CNY | -73.284% |